FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:WDR41-ADSL

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: WDR41-ADSL
FusionPDB ID: 98972
FusionGDB2.0 ID: 98972
HgeneTgene
Gene symbol

WDR41

ADSL

Gene ID

55255

158

Gene nameWD repeat domain 41adenylosuccinate lyase
SynonymsMSTP048AMPS|ASASE|ASL
Cytomap

5q13.3-q14.1

22q13.1

Type of geneprotein-codingprotein-coding
DescriptionWD repeat-containing protein 41adenylosuccinate lyaseadenylosuccinase
Modification date2020031320200315
UniProtAcc.

P30566

Main function of 5'-partner protein: FUNCTION: Catalyzes two non-sequential steps in de novo AMP synthesis: converts (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate (SAICAR) to fumarate plus 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide, and thereby also contributes to de novo IMP synthesis, and converts succinyladenosine monophosphate (SAMP) to AMP and fumarate. {ECO:0000269|PubMed:10888601}.
Ensembl transtripts involved in fusion geneENST idsENST00000296679, ENST00000507029, 
ENST00000414719, ENST00000512033, 
ENST00000480775, ENST00000216194, 
ENST00000342312, ENST00000454266, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score6 X 6 X 4=1445 X 8 X 5=200
# samples 77
** MAII scorelog2(7/144*10)=-1.04064198449735
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(7/200*10)=-1.51457317282976
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: WDR41 [Title/Abstract] AND ADSL [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: WDR41 [Title/Abstract] AND ADSL [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)WDR41(76754886)-ADSL(40750251), # samples:2
Anticipated loss of major functional domain due to fusion event.WDR41-ADSL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
WDR41-ADSL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneADSL

GO:0006167

AMP biosynthetic process

11428554



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:76754886/chr22:40750251)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across WDR41 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ADSL (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000296679WDR41chr576754886-ENST00000216194ADSLchr2240750251+23227873761839487
ENST00000296679WDR41chr576754886-ENST00000454266ADSLchr2240750251+19327873761839487
ENST00000296679WDR41chr576754886-ENST00000342312ADSLchr2240750251+21377873761662428
ENST00000507029WDR41chr576754886-ENST00000216194ADSLchr2240750251+1877342961394432
ENST00000507029WDR41chr576754886-ENST00000454266ADSLchr2240750251+1487342961394432
ENST00000507029WDR41chr576754886-ENST00000342312ADSLchr2240750251+1692342961217373

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000296679ENST00000216194WDR41chr576754886-ADSLchr2240750251+0.0016362580.9983638
ENST00000296679ENST00000454266WDR41chr576754886-ADSLchr2240750251+0.0031477240.99685234
ENST00000296679ENST00000342312WDR41chr576754886-ADSLchr2240750251+0.0021470620.9978529
ENST00000507029ENST00000216194WDR41chr576754886-ADSLchr2240750251+0.0011955090.99880445
ENST00000507029ENST00000454266WDR41chr576754886-ADSLchr2240750251+0.0023177810.9976822
ENST00000507029ENST00000342312WDR41chr576754886-ADSLchr2240750251+0.0011064480.99889356

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for WDR41-ADSL

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
WDR41chr576754886ADSLchr224075025134282QVQRISCFQSTVKLARVISRLADFAK
WDR41chr576754886ADSLchr2240750251787137QVQRISCFQSTVKLARVISRLADFAK

Top

Potential FusionNeoAntigen Information of WDR41-ADSL in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
WDR41-ADSL_76754886_40750251.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
WDR41-ADSLchr576754886chr2240750251787HLA-A02:22KLARVISRL0.98980.57031221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:13KLARVISRL0.98560.65931221
WDR41-ADSLchr576754886chr2240750251787HLA-B15:16STVKLARVI0.98050.6765918
WDR41-ADSLchr576754886chr2240750251787HLA-A02:27KLARVISRL0.97690.59291221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:38KLARVISRL0.97450.63341221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:30KLARVISRL0.97310.67391221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:67KLARVISRL0.97310.67391221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:24KLARVISRL0.97310.67391221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:60KLARVISRL0.9730.61071221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:11KLARVISRL0.97290.69881221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:04KLARVISRL0.96740.61491221
WDR41-ADSLchr576754886chr2240750251787HLA-A32:13KLARVISRL0.96690.91351221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:21KLARVISRL0.96590.8031221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:16KLARVISRL0.95360.64251221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:29KLARVISRL0.87540.67921221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:35KLARVISRL0.84630.70371221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:20KLARVISRL0.82050.67261221
WDR41-ADSLchr576754886chr2240750251787HLA-B13:02KLARVISRL0.0560.61871221
WDR41-ADSLchr576754886chr2240750251787HLA-B13:01KLARVISRL0.04760.88461221
WDR41-ADSLchr576754886chr2240750251787HLA-C15:06STVKLARVI0.99650.7466918
WDR41-ADSLchr576754886chr2240750251787HLA-A02:07KLARVISRL0.97360.68711221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:01KLARVISRL0.97310.67391221
WDR41-ADSLchr576754886chr2240750251787HLA-C03:19SCFQSTVKL0.95490.9902514
WDR41-ADSLchr576754886chr2240750251787HLA-B15:04KLARVISRL0.91910.85721221
WDR41-ADSLchr576754886chr2240750251787HLA-C12:04STVKLARVI0.85560.9599918
WDR41-ADSLchr576754886chr2240750251787HLA-C06:03STVKLARVI0.85470.9516918
WDR41-ADSLchr576754886chr2240750251787HLA-C15:02STVKLARVI0.99720.5972918
WDR41-ADSLchr576754886chr2240750251787HLA-C15:05STVKLARVI0.99660.6232918
WDR41-ADSLchr576754886chr2240750251787HLA-A02:03KLARVISRL0.99340.74351221
WDR41-ADSLchr576754886chr2240750251787HLA-A32:01KLARVISRL0.99210.94161221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:14KLARVISRL0.96610.75141221
WDR41-ADSLchr576754886chr2240750251787HLA-A02:06KLARVISRL0.96590.8031221
WDR41-ADSLchr576754886chr2240750251787HLA-C03:05SCFQSTVKL0.87790.9107514
WDR41-ADSLchr576754886chr2240750251787HLA-B15:73KLARVISRL0.76360.6851221
WDR41-ADSLchr576754886chr2240750251787HLA-B15:30KLARVISRL0.6220.71941221
WDR41-ADSLchr576754886chr2240750251787HLA-C03:06SCFQSTVKL0.61970.9898514
WDR41-ADSLchr576754886chr2240750251787HLA-B35:13SCFQSTVKL0.5310.9266514
WDR41-ADSLchr576754886chr2240750251787HLA-A32:01RISCFQSTVKL0.97990.9721314

Top

Potential FusionNeoAntigen Information of WDR41-ADSL in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
WDR41-ADSL_76754886_40750251.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
WDR41-ADSLchr576754886chr2240750251787DRB5-0106QSTVKLARVISRLAD823

Top

Fusion breakpoint peptide structures of WDR41-ADSL

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
814CFQSTVKLARVISRWDR41ADSLchr576754886chr2240750251787

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of WDR41-ADSL

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN814CFQSTVKLARVISR-7.14368-7.25548
HLA-B14:023BVN814CFQSTVKLARVISR-6.90724-7.95034
HLA-B52:013W39814CFQSTVKLARVISR-7.67666-8.71976
HLA-B52:013W39814CFQSTVKLARVISR-5.5221-5.6339
HLA-A11:014UQ2814CFQSTVKLARVISR-8.37369-9.41679
HLA-A11:014UQ2814CFQSTVKLARVISR-6.26273-6.37453
HLA-A24:025HGA814CFQSTVKLARVISR-7.6158-8.6589
HLA-A24:025HGA814CFQSTVKLARVISR-5.36701-5.47881
HLA-B44:053DX8814CFQSTVKLARVISR-8.09865-8.21045
HLA-B44:053DX8814CFQSTVKLARVISR-5.97829-7.02139

Top

Vaccine Design for the FusionNeoAntigens of WDR41-ADSL

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
WDR41-ADSLchr576754886chr22407502511221KLARVISRLAAGCTTGCCAGAGTGATCTCTCGGCTT
WDR41-ADSLchr576754886chr2240750251314RISCFQSTVKLAGAATATCATGCTTCCAGTCTACTGTAAAGCTT
WDR41-ADSLchr576754886chr2240750251514SCFQSTVKLTCATGCTTCCAGTCTACTGTAAAGCTT
WDR41-ADSLchr576754886chr2240750251918STVKLARVITCTACTGTAAAGCTTGCCAGAGTGATC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
WDR41-ADSLchr576754886chr2240750251823QSTVKLARVISRLADCAGTCTACTGTAAAGCTTGCCAGAGTGATCTCTCGGCTTGCCGAC

Top

Information of the samples that have these potential fusion neoantigens of WDR41-ADSL

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
Non-CancerWDR41-ADSLchr576754886ENST00000296679chr2240750251ENST00000216194TCGA-EM-A1CV-11A

Top

Potential target of CAR-T therapy development for WDR41-ADSL

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to WDR41-ADSL

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to WDR41-ADSL

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource